Positive Impact Of COVID 19 On Diphtheria, Tetanus and Pertussis (DTP) Vaccine Market

According to a new report entitled “Diphtheria, Tetanus and Pertussis (DTP) Vaccine Market by Product, Age Group and End User: Opportunity Analysis and Industry Forecast from 2020 to 2027” by Allied Market Research, the tetanus and whooping cough vaccine market is It is expected to reach $7,0544 million by 2027 with an average annual growth rate of 5.1% in 2020-2027 at $4,758.8 million in 2019. The DTaP segment occupied a major market share in the overall DTP vaccine market by 2020

Key factors such as increased demand for DTaP vaccines and increased pertussis vaccine adoption worldwide drive the growth of the DTaP segment. In addition, high efficacy and increased demand in developing countries are expected to lead the market during the forecast period. In addition, introducing a new vaccine combination with DTaP provides opportunities for market participants.

Request a free sample report at https://www.alliedmarketresearch.com/request-sample/3810

Based on the age segment, due to the increase in the global obesity population, the child segment is expected to grow at a significant annual average growth rate of 4.9% over the forecast period. Vaccines for adults appear to have high growth potential due to an increased incidence of infectious diseases in adults. In addition, the growth of research and development and strong product pipelines also appear to increase the growth of this segment over the forecast period.

know more: https://www.alliedmarketresearch.com/diphtheria-pertussis-and-tetanus-vaccine-market

End-users have a large share of the DTP vaccine market in the hospital sector in 2019, and because these vaccines are faster to use in hospitals and shorter procedures. Hospitals are an integral part of the healthcare sector, serving as a major source of revenue generation and supporting research and innovation.

Purchase Inquiries: https://www.alliedmarketresearch.com/purchase-enquiry/3810

Key findings from the study
• DTaP is expected to be one of the most profitable segments with a CAGR of 5.0% over the forecast period.
• The pediatric division has the largest share of the global DTP vaccine market in 2019, and is expected to grow at a CAGR of 4.9% over the forecast period.
• The United States dominated the North American DTP vaccine market and is expected to maintain this trend throughout the forecast period.
• India is expected to have the highest growth rate in the Asia Pacific DTP vaccine market, with an average annual growth rate of 6.6% over the forecast period.
• South Africa is expected to have the highest growth rate in the LAMEA DTP vaccine market and an average annual growth rate of 5.5% over the forecast period.

In 2019, North America is expected to dominate during the forecast period due to the high awareness and demand for DTaP vaccines and the presence of key key players along with R&D laboratories. In addition, the extensive availability of advanced systems complements the growth of the DTP vaccine market. However, the Asia-Pacific region is expected to show the highest CAGR during the forecast period due to increased awareness of countries such as India and China.

The major players in the DTaP vaccine market worldwide are AJ vaccine, Bionet-Asia, GlaxoSmithKline plc (GSK), Johnson & Johnson, Massbiologics, Meiji Holdings Co., Ltd. (KM biologics co., Ltd.), Merck & Co. , Inc., Panacea Biotec Ltd., Sanofi and Serum Institute of India Pvt. Corporation

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web:https://www.alliedmarketresearch.com
Follow Us on LinkedIn:https://www.linkedin.com/company/allied-market-research

About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.